4.4 Letter

A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia

Journal

SCHIZOPHRENIA RESEARCH
Volume 82, Issue 1, Pages 115-117

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2005.10.001

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available